Preferred Label : Risedronic Acid;
MeSH definition : An aminobisphosphonate derivative of etidronic acid and CALCIUM CHANNEL BLOCKER that
inhibits BONE RESORPTION and is used for the treatment of OSTEOPOROSIS.; A pyridine and diphosphonic acid derivative that acts as a CALCIUM CHANNEL BLOCKER
and inhibits BONE RESORPTION.;
CISMeF synonym : Acid, Risedronic;
MeSH Hyperonym : Risedronic Acid;
MeSH hyponym : bisphosphate risedronate sodium; atelvia; Actonel; 2-(3-pyridinyl)-1-hydroxyethylidenebisphosphonate; Risedronate Sodium, Bisphosphonate; Sodium, Bisphosphonate Risedronate;
MeSH CAS label : Phosphonic acid, (1-hydroxy-2-(3-pyridinyl)ethylidene)bis-;
MeSH Related Number : KM2Z91756Z (Risedronic Acid); OFG5EXG60L;
Registry Number MeSH : OFG5EXG60L;
Wikipedia link : https://en.wikipedia.org/wiki/Risedronic acid;
Is substance : O;
UNII : KM2Z91756Z;
Origin ID : D000068296;
UMLS CUI : C0140610;
ATC code(s)
ATC code(s)
Allowable qualifiers
Currated CISMeF NLP mapping
Pharmacological action(s)
Record concept(s)
See also (suggested by CISMeF)
See also inter- (CISMeF)
Semantic type(s)
UMLS correspondences (same concept)
An aminobisphosphonate derivative of etidronic acid and CALCIUM CHANNEL BLOCKER that
inhibits BONE RESORPTION and is used for the treatment of OSTEOPOROSIS.
A pyridine and diphosphonic acid derivative that acts as a CALCIUM CHANNEL BLOCKER
and inhibits BONE RESORPTION.
http://www.has-sante.fr/portail/jcms/c_1751307/fr/les-medicaments-de-losteoporose
2023
false
true
false
France
French
bone density conservation agents
osteoporosis
treatment outcome
alendronic acid
alendronate
guidelines for drug use
zoledronic acid
administration, oral
risedronic acid
denosumab
Raloxifene Hydrochloride
strontium ranelate
strontium ranelate
teriparatide
teriparatide
spinal fractures
hip fractures
costs and cost analysis
bone density conservation agents
drug costs
bone density
risk
osteoporosis, postmenopausal
adrenal cortex hormones
osteoporosis
osteoporotic fractures
alendronic acid and colecalciferol
drugs, generic
infusions, intravenous
risedronic acid, calcium and colecalciferol, sequential
injections, subcutaneous
raloxifene
algorithms
Adrenocortical steroid therapy
corticosteroid therapy
Risedronic Acid
Denosumab
diphosphonates
imidazoles
organometallic compounds
thiophenes
Zoledronic Acid
---
https://www.has-sante.fr/portail/jcms/c_2801243/fr/actonel
2017
false
false
false
false
France
French
evaluation of the transparency committee
administration, oral
Risedronic Acid
Product containing precisely risedronate sodium 35 milligram/1 each gastro-resistant
oral tablet (clinical drug)
risedronic acid
osteoporosis, postmenopausal
osteoporotic fractures
spinal fractures
hip fractures
tablets, enteric-coated
treatment outcome
insurance, health, reimbursement
bone density conservation agents
---
http://www.inesss.qc.ca/fileadmin/doc/INESSS/Rapports/Medicaments/INESSS_Portrait_usage_osteoporose.pdf
2014
false
false
false
Canada
French
technical report
adult
aged
diphosphonates
osteoporotic fractures
alendronate
bone density conservation agents
imidazoles
medication adherence
vitamin D
calcium
calcium, dietary
osteoporosis
Risedronic Acid
Denosumab
Zoledronic Acid
---
http://www.has-sante.fr/portail/jcms/c_1716196/fr/actonelcombi
http://www.has-sante.fr/portail/jcms/c_1716195/fr/actonelcombi18122013avisct13351
http://www.has-sante.fr/portail/jcms/c_598216/fr/actonelcombi?xtmc=&xtcr=2
2013
false
France
French
evaluation of the transparency committee
drug combinations
administration, oral
drug therapy, combination
insurance, health, reimbursement
cholecalciferol
risedronic acid, calcium and colecalciferol, sequential
calcium carbonate
osteoporosis, postmenopausal
spinal fractures
hip fractures
bone density conservation agents
treatment outcome
Risedronic Acid
---
http://www.has-sante.fr/portail/jcms/c_1250038/actonel
http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-06/actonel_09052012_avis_ct9408.pdf
http://www.has-sante.fr/portail/jcms/c_677475/actonel
http://www.has-sante.fr/portail/jcms/c_545526/actonel
http://www.has-sante.fr/portail/jcms/c_400844/actonel
http://www.has-sante.fr/portail/jcms/c_459589/actonel
http://www.has-sante.fr/portail/jcms/c_399785/actonel
http://www.has-sante.fr/portail/jcms/c_399357/actonel
2012
false
France
French
evaluation of the transparency committee
corticosteroid therapy
hemipenta hydrate risedronate monosodium
Risedronic Acid
etidronic acid
administration, oral
-
insurance, health, reimbursement
bone density conservation agents
risedronic acid
osteoporosis, postmenopausal
spinal fractures
osteoporosis, postmenopausal
hip fractures
osteitis deformans
osteoporosis
---
http://www.cochrane.org/fr/CD004523
2010
false
true
false
United Kingdom
France
Risedronic Acid
treatment outcome
review of literature
french abstract
osteoporotic fractures
postmenopause
---
https://www.cadth.ca/sites/default/files/pdf/371_bisphosphonates_tr_f.pdf
https://www.cadth.ca/fr/meta-analyse-des-bisphosphonates-dans-la-prevention-primaire-et-la-prevention-secondaire-des
2006
true
Canada
French
Risedronic Acid
bone density conservation agents
diphosphonates
osteoporosis, postmenopausal
alendronate
fractures, bone
fractures, bone
economics, pharmaceutical
bisphosphonates
meta-analysis
economic evaluation
drug evaluation
---